Piermont Valley Acquisition Corp

Beyond redemption mechanics, the filing outlines significant legal and operational parameters. According to Exhibit 10.1, the investor represents it is an institutional accredited investor located at 601 California Street, Suite 1151, San Francisco, CA 94108, and covenants to vote all owned ordinary shares in favor of the extension proposals. The agreement grants the investor registration rights under a November 30, 2021 Registration Rights Agreement, waives Rule 10b-5 claims concerning potential material non-public information, and subjects disputes to New York jurisdiction with a jury trial waiver. Registered securities confirmed in the cover page include units (CMCAU), Class A ordinary shares with a $0.0001 par value (CMCAF), and warrants with a $11.50 exercise price (CMCAW). Chairman and Chief Executive Officer Wei Qian countersigned the report alongside sponsor signatory Xinying Wu. The filing contains no revenue projections, customer data, or technological disclosures.

Trust per-share value is approximately $11.91, but the company faces a working capital deficit of $180,537 and a going concern qualification. The deadline to complete a business combination is March 3, 2026. The new sponsor has not yet identified a target. The cancellation of private warrants and debt forgiveness by the prior sponsor are significant sponsor conduct events that improve the balance sheet but underscore the company's distressed state.

The sponsor transition and subsequent cleanup of liabilities (private warrant cancellation, debt forgiveness) materially restructured the balance sheet, reducing the prior sponsor's influence and likely clearing the path for a new business combination deal. The tiny remaining trust ($2.42M) and working capital deficit highlight extreme liquidity risk and the need for a new sponsor to fund operations and a deal. The auditor change and prior material weakness in internal controls over financial reporting ('lack of qualified SEC reporting professional') persist, as disclosure controls were deemed not effective.

The filing indicates the SPAC likely liquidated after quarter-end, with the trust fully depleted in August 2025. This means no business combination will occur. Investors should expect final distributions. The sponsor change and auditor dismissal are also significant. The net loss and working capital deficit highlight ongoing cash burn.

This filing materially alters the redemption timeline and trust dynamics for CMCAF investors. According to the Board, shareholders must decide whether to tender shares at an estimated $11.97 each before the March 2026 lapse or retain them for potential future redemption under a one-year extension, accepting the risk that sponsor-backed indemnification may not fully cover trust depletion if third-party claims arise. The proxy statement emphasizes that the New Sponsor's control of approximately 96.6% of voting shares effectively precludes minority opposition to the extension, underscoring limited minority shareholder influence. Management highlighted that the unilateral cancellation of 11,700,000 private placement warrants by prior sponsors removes significant future equity dilution. The filing discloses a $1,000,000 loan from the New Sponsor (convertible into warrants at $1.50 each, capped at $1,500,000 total) and ongoing search efforts post-Nasdaq delisting, which signals continued, albeit delayed, deal pursuit according to company statements. Investors tracking trust liquidity, extension triggers, and sponsor conduct will find this document critical for modeling redemption economics and evaluating management's timeline credibility.

The company is in a pre-deal state with a fully depleted trust account and no identified target. It has a going concern qualification from its auditors and discloses material weaknesses in internal controls. The deadline for a business combination is March 3, 2026, but without trust funds and with ongoing operating costs funded by related-party loans, the path to completing a deal or surviving to the deadline is uncertain. The sponsor change introduces new management and potential deal terms.

The filing indicates repeated failure to close a target despite multiple prior extensions following the December 3, 2021 IPO ($241,700,000 gross proceeds). Historical redemptions removed approximately $197.2 million in 2023, $33.6 million in 2024, and $11.64 million in 2025, progressively draining the Trust Account. Voting control is heavily concentrated with the New Sponsor (~96.6%), removing typical public holder leverage during extension negotiations. The document records the March 22, 2024 termination of the Lexasure Financial Group limited merger, successive sponsor transfers from CEMAC Sponsor LP to Vikasati Partners LLC to Valleypark Road, LLC, and the cancellation of 11,700,000 private placement warrants, reflecting prolonged search activity and sponsor restructuring. Material risk disclosures note that securities were delisted from Nasdaq, may trade OTC under Rule 419 penny stock conditions, face potential classification as an unregistered investment company due to extended duration, and could trigger the Inflation Reduction Act’s 1% excise tax on redemptions if U.S. domesticated. The proxy includes comprehensive U.S. federal income tax analysis for redeeming shareholders addressing PFIC treatment, Section 302 sale-or-exchange versus dividend characterization, FATCA withholding, and backup withholding protocols.

The working capital facility provides immediate liquidity for deal pursuit while explicitly excluding trust account funds from its repayment obligation, preserving existing redemption economics for shareholders should the SPAC liquidate. The optional warrant conversion at $1.50 introduces a defined dilution pathway upon closing that could affect post-merger capitalization tables. The auditor transition, occurring after CBIZ CPAs P.C. acquired Marcum LLP's attest business on November 1, 2024, combined with the renewed citation of historical going concern qualifications and internal control material weaknesses, indicates ongoing structural and compliance monitoring ahead of the company's operational timeline. The filing contains no claims, data, or projections regarding customers, revenue, market size, technology, strategic partnerships, or target entity litigation.

This insider share reduction does not alter the redemption deadline, trust per share valuation, or the announced deal status, but the $0 execution price and ‘other’ transaction classification signal a non-market corporate action—such as a conversion, cancellation, or inter-affiliate transfer—that directly reshapes post-combination equity distribution and sponsor/related-party holding concentrations, which investors monitor when assessing capital structure and redemption dynamics. According to the document, the reporting persons made no statements regarding customer portfolios, revenue trajectories, market sizing, strategic initiatives, technology pipelines, commercial partnerships, legal disputes, or executive appointments beyond their stated governance titles and precise share balances.

The filing establishes a complete leadership and equity handover, moving control from the founding sponsors to a new purchaser who now directs proxy voting and board appointments. The explicit $100 transaction price and the irrevocable waiver of claims against the Trust Account by both the Acquiror and Sponsor (per Section 20) insulate the $2,400,000 trust from third-party recourse, preserving those funds strictly for public redemptions or a successful business combination. By cancelling 11,700,000 warrants, the agreement permanently removes those instruments from circulation, directly reducing headline dilution. The March 3, 2026 deadline remains firm, meaning redemption timing and extension decisions hinge entirely on whether the new governing body advances a target before that date. Additionally, Item 5.02 describes Wei Qian’s background, noting he previously served as an independent director of Battery Future Acquisition Corp until its April 2025 combination, and his expertise spans TMT, healthcare, and climate tech, signaling an active pivot toward deal sourcing, though the filing contains no announced target, customer lists, revenue projections, or market size data.

The extension pushes the mandatory liquidation window forward by one full year, delaying when uncommitted trust funds become payable upon dissolution and altering the liquidity timeline for public shareholders. Removing the US$5,000,001 net tangible asset floor eliminates a structural barrier to share redemptions, which may accelerate trust fund withdrawals if holders opt for cash payouts ahead of any potential business combination. The updated outstanding share count of 5,954,986 Class A Ordinary Shares and 1 Class B Ordinary Share establishes the new baseline for per-share trust valuations and voting weight. Unanimous approval across all proposals signals broad holder alignment behind the sponsor’s extension request, mitigating near-term dissolution risk. The documented name change solely updates market identification and does not alter securities structure, warrant terms, or underlying trust capital.

The Non-Redemption Agreement establishes a concrete redemption floor ahead of the extension vote, directly influencing post-vote trust liquidity and the financial feasibility of a subsequent business combination. The 200,000-to-80,000 share swap ratio pricing mechanism creates an explicit valuation benchmark for non-trusting shareholders and triggers a most-favoured-nations clause that could force the sponsor to offer identical 2-to-1 economics to any future counterparties. Additionally, Exhibit B and Section 1.2 create a carved-out exception to the standard November 30, 2021, Letter Agreement by exempting the investor’s public shares from trust-account liquidation and voting restrictions, thereby reallocating traditional sponsor protection while still binding the investor to registration rights obligations.

If the Extension Amendment fails, or if the Redemption Limitation Amendment fails and post-redemption net tangible assets drop below US$5,000,001, the Company states it will be forced to dissolve and liquidate the Trust Account by March 3, 2025. Approval extends the business combination search but keeps redemption rights alive; however, redemption payments are strictly contingent on extension approval. The Prior Sponsor and New Sponsor collectively control approximately 82.6% of outstanding ordinary shares and have declared they intend to vote 'FOR' all proposals, effectively securing passage. Public warrants and 11,700,000 Private Placement Warrants (each exercisable for one Class A ordinary share at $11.50 per share) will survive an extension but expire worthless upon liquidation. The Company warns that the Prior Sponsor's indemnity obligation to cover trust shortfalls down to $10.20 per public share may be unfulfillable because the Company believes the Prior Sponsor's only assets are company securities, and no officers or directors provide similar indemnification. Shareholders face an immediate liquidity decision with a hard submission deadline, while unit holders must first separate underlying warrants before exercising redemption rights.

The Board explicitly states there will not be sufficient time to consummate an initial business combination by the original March 3, 2025 deadline, making the extension critical to avoid mandatory liquidation. Without the Redemption Limitation Amendment, significant redemptions triggered by the extension could legally force the Company to dissolve on March 3, 2025, as the remaining net tangible assets would fall under the US$5,000,001 threshold. The proposed name change and recent sponsor security transfers indicate shifting management control and branding ahead of any future target search, though no definitive acquisition is currently pending. Shareholders are presented with a clear exit mechanism at the current Trust Account pro-rata value and must decide whether to approve the extensions and waiver or accept liquidation. The Board unanimously recommends voting FOR all proposals.

The filing formally advances the exchange delisting process, meaning the securities will cease trading on Nasdaq following the Form 25 filing and its associated ten-day waiting period. This transition typically reduces secondary market liquidity and alters ongoing surveillance and reporting obligations for the issuer and its securities. Because the text restricts itself to exchange listing notifications and omits any references to the SPAC’s merger timeline, trust account status, shareholder redemption windows, or management actions, it does not modify the core economic or structural mechanics investors monitor for this vehicle.

Exchange removal strips the securities of institutional custody eligibility, index tracking, and standard clearing infrastructure. For investors tracking redemption mechanics and sponsor conduct, suspension eliminates real-time price discovery and forces trading onto over-the-counter channels, complicating timing for outflow elections and arbitrage strategies. The confirmed Panel denial removes administrative relief pathways, confirming sustained listing deficiency and heightening scrutiny on whether the sponsor will pursue a formal extension or accelerate merger completion before capital dissipation triggers are reached.

The reporting lags signal potential internal accounting or sponsor-level processing bottlenecks that investors should monitor against the stated deadline and deal progress milestones. The Registrant asserts it is currently in the preliminary stage of preparing the June 30, 2024 financials and therefore cannot reasonably estimate earnings results for the period. As a purely administrative regulatory notice, the document contains no substantive claims regarding target customer concentration, revenue projections, market size estimates, strategic pivots, technology developments, partnership formations, active litigation, or executive compensation changes. All statements are exclusively attributable to the Registrant and its authorized officers.

Delayed annual reporting creates regulatory compliance visibility issues and can compress operational windows for shareholder approvals, regulatory submissions, or deal closings. Although the filing does not tie the postponement to the stated March 3, 2027 business combination deadline or any trust distribution framework, extended financial statement preparation cycles often constrain a SPAC’s ability to rapidly execute merger votes or liquidity events, making the filing material to investors monitoring execution risk, sponsor reliability, and timeline adherence.

The delisting removes the securities from a national exchange listing framework, shifting them to the OTC Pink Market and potentially restricting institutional liquidity and retail access ahead of any contractual liquidation deadline. Nasdaq’s ruling reflects persistent shareholder base erosion rather than operational deterioration, and the Company provided no updates on target identification, merger agreements, or sponsor funding commitments. CEO Suresh Guduru attested to the administrative filings without addressing potential redemption windows or warrant exercise conditions, though the warrant exercisability for one Class A ordinary share at an exercise price of $11.50 per share remains listed in the security registration metadata. Because the filing contains no claims regarding customer relationships, revenue streams, market sizing, technological strategy, partnership developments, active litigation, or key personnel changes beyond the signatory, investors cannot derive information on trust distributions, extension votes, or acquisition milestones from this submission alone.

The filing discloses a complete sponsor and board turnover ahead of the business combination, restructuring the equity incentive and funding landscape. Lowering sponsor share forfeitures reduces dilution pressure on public shareholders relative to the original extension framework, while replacing equity vesting with direct cash payments to second-extension participants shifts compensation costs to New Sponsor. Terminating the forward purchase commitment, working capital facility, administrative fee arrangement, and underwriter deferrals strips away contingent liabilities and future capital calls before closing. The five newly appointed directors—Suresh Guduru, Brian Coad, John Levy, Suresh Singamsetty, and Kishore Kondragunta—were recruited based on disclosed expertise in IoT platforms, retail supply chains, and independent public accounting, though the filing contains no statements regarding the target company, prospective revenue, market opportunity, merger timeline, or trust account valuation.

Exchange delisting determinations introduce direct secondary market liquidity risk and may force listed equity into unregulated trading channels if the Hearings Panel declines to grant relief. The explicit disclaimer that ‘There can be no assurance that the hearing before the Panel will be successful’ highlights unresolved binary risk for existing shareholders. Because this 8-K addresses exclusively listing qualification maintenance, it supplies no updated mechanics regarding shareholder redemptions, trust balances, merger milestones, or sponsor governance, meaning investors tracking those SPAC-specific parameters receive zero new operational guidance from this submission.

The termination permanently abandons the merger pathway for Lexasure Financial Group Limited, eliminating the public listing scenario and triggering the immediate expiration of prior equity holds, voting pacts, and executive restrictions. Because the settlement retains the original Section 9.1 trust waiver provision, the filing confirms that shareholder redemption entitlements and trust fund protections remain fully intact and unwaived despite the deal collapse. The indefinite covenant not to sue and the express waiver of unknown/unanticipated claims under Section 1.3(b) are structured to foreclose follow-on litigation over the aborted transaction. Additional substantive terms include a New York governing law clause, exclusive jurisdiction in New York courts, irrevocable jury trial waivers, carve-outs allowing specific performance without bonding, and acknowledgment that the agreement supersedes all prior contemporaneous understandings.

The filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, or ongoing litigation. The only additional personnel matter documented is Mr. Faber's February 23, 2024 resignation, which streamlined the nomination slate ahead of Ms. Baker's shareholder-backed re-appointment. For investors tracking capital structures, the mechanical shift is definitive: the amended calendar pushes the liquidation or merger trigger to March 3, 2025, while the redemption event drained approximately $33.61685 million from the trust at premium pricing. The resulting reduction in public share count concentrates voting authority with the sponsor, fundamentally altering the governance ratio and available cash pool without introducing new commercial targets or operational disclosures.

The SEC Staff's identification of a Nasdaq listing-rule conflict injects immediate exchange compliance risk ahead of the shareholder vote. If the company fails to reconcile the 39-month extension request with the 36-month Nasdaq mandate, The Nasdaq Capital Market could suspend trading or delist the SPAC's equity, which would directly impede shareholder redemption mechanics, erode liquidity, and threaten the sponsor's ability to finance or close a business combination by the stated March 3, 2025 deadline. Tracking the required ten-business-day response will clarify whether the sponsor intends to obtain a formal Nasdaq exception, inject additional capital to meet exchange standards, or restructure the proxy disclosures to limit delisting penalties. Redemption rights holders should assess this listing vulnerability alongside deal execution timelines when deciding whether to hold, sell, or exercise put options.

What changed: A Form 8-K current report detailing the submission of matters to a vote of security holders and subsequent amendments to the memorandum and articles of association, formally documenting shareholder approval of a business combination deadline extension and the resulting share redemptions. The company reports that at an extraordinary general meeting on March 2, 2026, shareholders voted 5,950,000 For, 0 Against, 1 Abstain, and 0 Broker Non-Votes to approve an amendment extending the required business combination consummation date from March 3, 2026 to March 3, 2027. The filing states that an aggregate of 536 shares were redeemed in connection with the extension, leaving 5,954,419 Class A Ordinary Shares and 1 Class B Ordinary Share outstanding. The revised articles preserve the board's sole discretion to elect to wind up operations before the new deadline. The report is dated and executed by Chairman and Chief Executive Officer Wei Qian. Why it matters: The extension defers the mandatory liquidation trigger by one full year, shifting the SPAC's termination exposure from March 2026 to March 2027 and indicating the sponsor's intention to continue deal execution rather than pursue a default redemption. The redemption volume was immaterial (536 shares), meaning nearly all remaining trust capital stays available for a future business combination. Because this filing is strictly an administrative governance update surrounding the extension vote, it contains no information on deal progress, target selection, valuation, sponsor support agreements, or current trust account balances.

What changed: A Form 8-K Current Report disclosing the entry into a Material Definitive Agreement, specifically a Non-Redemption Agreement and Assignment of Economic Interest (Exhibit 10.1), executed by Piermont Valley Acquisition Corp, its sponsor Valleypark Road LLC, and third-party investor Funicular Funds, LP. The sponsor entered into a binding arrangement to compensate Funicular Funds, LP with 90,000 Founder Shares—transferred concurrently with any future business combination closing—in exchange for the investor's agreement not to redeem 200,000 Class A ordinary shares at the forthcoming extraordinary general meeting. The 8-K (Item 1.01) states this agreement is designed to increase funds retained in the company’s trust account following the extension vote. It corroborates the proxy statement filed February 9, 2026, which proposes amending the Charter to push the initial business combination deadline to March 3, 2027. Why it matters: Beyond redemption mechanics, the filing outlines significant legal and operational parameters. According to Exhibit 10.1, the investor represents it is an institutional accredited investor located at 601 California Street, Suite 1151, San Francisco, CA 94108, and covenants to vote all owned ordinary shares in favor of the extension proposals. The agreement grants the investor registration rights under a November 30, 2021 Registration Rights Agreement, waives Rule 10b-5 claims concerning potential material non-public information, and subjects disputes to New York jurisdiction with a jury trial waiver. Registered securities confirmed in the cover page include units (CMCAU), Class A ordinary shares with a $0.0001 par value (CMCAF), and warrants with a $11.50 exercise price (CMCAW). Chairman and Chief Executive Officer Wei Qian countersigned the report alongside sponsor signatory Xinying Wu. The filing contains no revenue projections, customer data, or technological disclosures.

What changed: A quarterly report (Form 10-Q) for Piermont Valley Acquisition Corp (formerly Capitalworks Emerging Markets Acquisition Corp) for the period ended September 30, 2025, filed by CEO Wei Qian. The document includes unaudited financial statements, management's discussion and analysis, and routine certifications. This 10-Q reports no new target deal progress; the SPAC remains a shell company seeking a business combination with a deadline of March 3, 2026. The trust account held approximately $2.42 million as of September 30, 2025, down from $2.38 million at March 31, 2025, per the Company's statements. There has been a sponsor transition: on July 11, 2025, Valleypark Road, LLC acquired control from Vikasati Partners, resulting in the cancellation of all 11,700,000 private placement warrants and the forgiveness/write-off of various related-party liabilities, recorded as capital contributions reducing shareholders' deficit. The independent auditor was changed from Marcum LLP to Aloba, Awomolo & Partners in August 2025, and the company was delisted from Nasdaq. The working capital deficit grew to $161,390 as of September 30, 2025, and management reiterates substantial doubt about the ability to continue as a going concern. Why it matters: The sponsor transition and subsequent cleanup of liabilities (private warrant cancellation, debt forgiveness) materially restructured the balance sheet, reducing the prior sponsor's influence and likely clearing the path for a new business combination deal. The tiny remaining trust ($2.42M) and working capital deficit highlight extreme liquidity risk and the need for a new sponsor to fund operations and a deal. The auditor change and prior material weakness in internal controls over financial reporting ('lack of qualified SEC reporting professional') persist, as disclosure controls were deemed not effective.

What changed: Form 10-Q quarterly report for the period ended December 31, 2025. Financial statements show continued operating losses; trust account reduced to $2.44 million with only 204,986 shares subject to possible redemption; sponsor transition completed in July 2025 with Valleypark Road LLC acquiring control, cancellation of 11,700,000 private placement warrants, waiver of $1,471,195 note payable, and forgiveness of $400,068 due to related party; auditor changed from Marcum LLP to Aloba, Awomolo & Partners; new working capital loan from Valleypark of up to $1,000,000; no new business combination announced. Why it matters: Trust per-share value is approximately $11.91, but the company faces a working capital deficit of $180,537 and a going concern qualification. The deadline to complete a business combination is March 3, 2026. The new sponsor has not yet identified a target. The cancellation of private warrants and debt forgiveness by the prior sponsor are significant sponsor conduct events that improve the balance sheet but underscore the company's distressed state.

What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2025, filed by Piermont Valley Acquisition Corp (formerly Capitalworks Emerging Markets Acquisition Corp). Trust account balance was $2,403,485 as of June 30, 2025, representing approximately $11.73 per share for 204,986 shares subject to redemption. The company had extended its deadline to March 3, 2026, but subsequent events reveal that the trust was liquidated in August 2025 and all public shares redeemed. No business combination was completed. Sponsor changed in July 2025 from Vikasati Partners to Valleypark. Auditor changed from Marcum to Aloba in August 2025. The company reported a net loss of $897,045 for the quarter. Why it matters: The filing indicates the SPAC likely liquidated after quarter-end, with the trust fully depleted in August 2025. This means no business combination will occur. Investors should expect final distributions. The sponsor change and auditor dismissal are also significant. The net loss and working capital deficit highlight ongoing cash burn.

What changed: A definitive proxy statement (DEF 14A) filed by Piermont Valley Acquisition Corp to solicit shareholder votes at an extraordinary general meeting on March 2, 2026 regarding an Extension Amendment to prolong the business combination deadline and a procedural Adjournment Proposal. The Board stated that the company proposes amending its charter to extend the business combination deadline from March 3, 2026 to March 3, 2027, while reserving Board discretion to liquidate operations earlier. The Company calculated that based on approximately $2.45 million in the Trust Account as of February 6, 2026, the estimated pro rata redemption price would be approximately $11.97 per public share before tax adjustments. Valleypark Road, LLC (the 'New Sponsor') reported owning 2,238,999 Class A ordinary shares and 1 Class B ordinary share, with voting authority over an additional 3,511,000 Class A ordinary shares from prior sponsors, representing approximately 96.6% of outstanding ordinary shares; the New Sponsor intends to vote all such shares in favor of the extension. According to the proxy statement, prior sponsors agreed to cancel an aggregate of 11,700,000 private placement warrants. Management confirmed there is insufficient time before March 3, 2026 to consummate a business combination and disclosed that the parties previously terminated the Lexasure Business Combination Agreement on March 22, 2024. The Board further stated that prior sponsors have agreed to indemnify the company to ensure trust proceeds are not reduced below $10.20 per public share by certain third-party claims. Why it matters: This filing materially alters the redemption timeline and trust dynamics for CMCAF investors. According to the Board, shareholders must decide whether to tender shares at an estimated $11.97 each before the March 2026 lapse or retain them for potential future redemption under a one-year extension, accepting the risk that sponsor-backed indemnification may not fully cover trust depletion if third-party claims arise. The proxy statement emphasizes that the New Sponsor's control of approximately 96.6% of voting shares effectively precludes minority opposition to the extension, underscoring limited minority shareholder influence. Management highlighted that the unilateral cancellation of 11,700,000 private placement warrants by prior sponsors removes significant future equity dilution. The filing discloses a $1,000,000 loan from the New Sponsor (convertible into warrants at $1.50 each, capped at $1,500,000 total) and ongoing search efforts post-Nasdaq delisting, which signals continued, albeit delayed, deal pursuit according to company statements. Investors tracking trust liquidity, extension triggers, and sponsor conduct will find this document critical for modeling redemption economics and evaluating management's timeline credibility.

What changed: Form 10-K annual report for the fiscal year ended March 31, 2025, which includes audited financial statements, MD&A, risk factors, and corporate governance information. The 10-K reports a net income of $1.6 million for FY2025, trust account value of approximately $2.38 million as of 3/31/2025, and a working capital deficit of $1.99 million. The company extended its deadline to complete a business combination to March 3, 2026, via the 'Third Extension'. Redemptions of 1,066,745 Class A shares at ~$10.91 each reduced the trust. The company's sponsor changed to Valleypark Road LLC on 7/11/2025, which included the cancellation of 11.7 million private placement warrants and a new working capital loan of up to $1 million. The trust was fully depleted in August 2025 and all public shares were redeemed for a total of $2,382,346. Why it matters: The company is in a pre-deal state with a fully depleted trust account and no identified target. It has a going concern qualification from its auditors and discloses material weaknesses in internal controls. The deadline for a business combination is March 3, 2026, but without trust funds and with ongoing operating costs funded by related-party loans, the path to completing a deal or surviving to the deadline is uncertain. The sponsor change introduces new management and potential deal terms.

What changed: Preliminary Proxy Statement (PRE 14A) and Notice of Extraordinary General Meeting soliciting shareholder votes on a charter amendment and adjournment proposal. The Company’s board of directors proposes extending the deadline to consummate an initial business combination from March 3, 2026 to March 3, 2027, while reserving sole Board discretion to liquidate operations earlier than that date. Public shareholders may elect to redeem their Class A ordinary shares at a pro rata portion of the Trust Account (including net interest minus applicable taxes) if they properly tender shares to Continental Stock Transfer & Trust Company by 5:00 p.m. Eastern Time on February 26, 2026. Valleypark Road, LLC (the 'New Sponsor') holds 2,238,999 Class A ordinary shares and 1 Class B ordinary share, with irrevocable voting authority over 3,511,000 additional Class A ordinary shares from the Prior Sponsors, representing approximately 96.6% of outstanding shares; the New Sponsor intends to vote all such shares in favor of the proposal. If the Extension Amendment Proposal fails, the Company will be required to cease operations, redeem all public shares, and distribute remaining Trust funds (less taxes and up to $100,000 for winding-up and dissolution expenses) to public shareholders, with all warrants expiring worthless. The Prior Sponsors have contractually agreed to indemnify the Company so that Trust proceeds do not fall below $10.20 per public share upon liquidation. The proxy states that as of February __, 2026, the Trust Account held approximately $__ million, yielding an estimated per-share redemption price of approximately $___ before tax adjustments. Why it matters: The filing indicates repeated failure to close a target despite multiple prior extensions following the December 3, 2021 IPO ($241,700,000 gross proceeds). Historical redemptions removed approximately $197.2 million in 2023, $33.6 million in 2024, and $11.64 million in 2025, progressively draining the Trust Account. Voting control is heavily concentrated with the New Sponsor (~96.6%), removing typical public holder leverage during extension negotiations. The document records the March 22, 2024 termination of the Lexasure Financial Group limited merger, successive sponsor transfers from CEMAC Sponsor LP to Vikasati Partners LLC to Valleypark Road, LLC, and the cancellation of 11,700,000 private placement warrants, reflecting prolonged search activity and sponsor restructuring. Material risk disclosures note that securities were delisted from Nasdaq, may trade OTC under Rule 419 penny stock conditions, face potential classification as an unregistered investment company due to extended duration, and could trigger the Inflation Reduction Act’s 1% excise tax on redemptions if U.S. domesticated. The proxy includes comprehensive U.S. federal income tax analysis for redeeming shareholders addressing PFIC treatment, Section 302 sale-or-exchange versus dividend characterization, FATCA withholding, and backup withholding protocols.

What changed: A Form 8-K current report disclosing a change in independent registered public accounting firm and the execution of a non-interest-bearing working capital promissory note. The Board of Directors of Piermont Valley Acquisition Corp dismissed Marcum LLP as its independent registered public accounting firm effective August 14, 2025, and appointed Aloba, Awomolo & Partners effective August 15, 2025. On August 14, 2025, Valleypark Road, LLC agreed to loan the Company up to $1,000,000 evidenced by a non-interest-bearing promissory note. Drawdowns require minimum requests of $10,000 and must be funded within three business days. The principal becomes repayable upon the earlier of a completed business combination or June 30, 2026. Upon a business combination, Valleypark Road, LLC retains an option to convert the outstanding principal into warrants at $1.50 per warrant, with conversion subject to applicable shareholder or target business approval. Piermont Valley Attribution Corp stated that if no business combination is consummated, the note and all amounts owed will be forgiven except to the extent the Company holds funds available outside its trust account. Marcum LLP's audit reports for the fiscal years ended March 31, 2023 and March 31, 2022 included a paragraph expressing substantial doubt about the Company's ability to continue as a going concern, and the Company referenced a previously disclosed material weakness in internal controls over accounting for complex financial instruments. Why it matters: The working capital facility provides immediate liquidity for deal pursuit while explicitly excluding trust account funds from its repayment obligation, preserving existing redemption economics for shareholders should the SPAC liquidate. The optional warrant conversion at $1.50 introduces a defined dilution pathway upon closing that could affect post-merger capitalization tables. The auditor transition, occurring after CBIZ CPAs P.C. acquired Marcum LLP's attest business on November 1, 2024, combined with the renewed citation of historical going concern qualifications and internal control material weaknesses, indicates ongoing structural and compliance monitoring ahead of the company's operational timeline. The filing contains no claims, data, or projections regarding customers, revenue, market size, technology, strategic partnerships, or target entity litigation.

What changed: SEC Form 3 insider ownership report. The Form 3, filed for Piermont Valley Acquisition Corp, attributes its disclosure entirely to reporting person Qian Wei, who holds the title of director. Per the filer’s explicit statement within the document, Qian Wei reports no non-derivative transactions or holdings. Why it matters: Because the Form 3 explicitly records zero beneficial ownership changes for the director, the filing does not alter the existing trust per share amount, does not impact the scheduled acquisition timeline, provides no evidence regarding deal progress or sponsor conduct, and contains no substantive commercial, technological, partnership, litigation, or strategic claims beyond identifying Qian Wei as a director.